Skip to main content
SpringerLink
Log in

Bevacizumab + sunitinib associated with MAHA

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Hoffmann-La Roche Limited.Association of microangiopathic haemolytic anemia (MAHA) with the combined use of AVASTIN (Rm) (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma. Internet Document: [3 pages], 11 Jul 2008. Available from: URL: http://www.hc-sc.gc.ca

  2. Genentech Inc.Microangiopathic hemolytic anemia (MAHA) in patients treated with Avastin (Rm) (bevacizumab) and sunitinib malate. Internet Document: [2 pages], Jul 2008. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab + sunitinib associated with MAHA. React. Wkly. 1211, 2 (2008). https://doi.org/10.2165/00128415-200812110-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812110-00004

Keywords

Search

Navigation